Husson University

Husson University, located in Bangor, Maine, is a private, non-profit educational institution registered in SAM.gov since 2001. As a corporate entity with tax-exempt status, the university provides specialized research and educational services to federal agencies, primarily focusing on advanced scientific research and institutional development. Through its business identity Nescom, Husson University engages with federal agencies to conduct cutting-edge research projects, particularly in pharmaceutical and health-related scientific investigations.

In terms of federal contract work, Husson University has demonstrated expertise in pharmaceutical research, most notably through a $584,639 firm-fixed-price contract with the Food and Drug Administration (FDA). This specific contract focused on developing advanced scientific research methodologies, specifically creating in vitro cell permeation models and utilizing in vitro to in vivo extrapolation (IVIVE) methods. The research project aimed to develop physiologically-based pharmacokinetic (PBPK) modeling for predicting the transfer of drugs and substances into human milk, particularly examining breast cancer resistant protein (BCRP) substrates. The contract was a direct award with no set-aside designation and no identified major subcontractors.

Regarding federal grant awards, Husson University has received multiple project grants from the U.S. Department of Education's Office of Postsecondary Education, totaling approximately $1.7 million. These grants span various initiatives, including advancing technology and improving human health through education, supporting student academic advising and programming, purchasing equipment, and receiving CARES Act Higher Education Emergency Relief Fund (HEERF) support. Notable grants include a $998,500 award to support research on drug transfer mechanisms, a $726,000 Congressionally Directed Community Project for equipment purchases, and multiple CARES Act grants to support institutional operations during the COVID-19 pandemic. The grants cover project periods ranging from 2020 to 2027, demonstrating the university's ongoing commitment to educational innovation, research, and institutional development.